GoodRx Holdings Inc

GoodRx Holdings Inc(GDRX)股票分析

$3.450

-0.010 (-0.29%)收盘时

Loading chart…
High
3.570
Open
3.460
VWAP
3.49
Vol
1.30M
Mkt Cap
2.89B
Low
3.450
Amount
4.53M
EV/EBITDA, TTM
7.58

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordable solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.

AI analysis of GoodRx Holdings Inc (GDRX)

buy

GoodRx Holdings Inc (GDRX) appears to be a good buy right now, trading at $3.53, which is below the average analyst target price of $4.50. The stock has shown a positive trend with a 20-day change of +14.98% and a year-to-date change of +28.36%. Although the RSI is at 48.888, indicating a neutral momentum, the forward P/E ratio of 5.4407 suggests that the stock is undervalued compared to its earnings potential. The main risk is the significant decline in Q2 earnings, reporting a net income of $8.54 million, down from $12.84 million last year, which may impact investor confidence.

估值指标

The current forward P/E ratio for GoodRx Holdings Inc (GDRX) is 5.44, compared to its 5-year average forward P/E of 43.96.

Forward P/E

Fair
5Y Average P/E
43.96
Current P/E
5.44
高估
654.16
低估
-566.23

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
14.20
Current EV/EBITDA
7.58
高估
28.18
低估
0.23

Forward P/S

Fair
5Y Average P/S
4.06
Current P/S
1.40
高估
8.38
低估
-0.26

Alphio AI Price Scenarios for GDRX

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%GDRX

$4.23

情景价格

B

Base

Base · 50%GDRX

$3.42

情景价格

B

Bear

Bear · 25%GDRX

$3.21

情景价格

Whales holding GDRX

S

Silver Lake Technology Management, L.L.C.

+ HoldingGDRX

+20.69%

3M Return

T

TCMI Inc.

+ HoldingGDRX

+16.93%

3M Return

事件时间线

2026-09-03 (ET)

09:30:00

GoodRx Launches Family Plan for $24.99 Monthly

2026-08-05 (ET)

17:31:00

GoodRx Q2 Revenue $200.4M, Exceeds Consensus

17:30:00

Raises FY26 Adjusted EBITDA Outlook to $240M-$250M

2026-05-27 (ET)

09:10:00

GoodRx Launches GoodRx Companion Subscription at $14.99 per Month

2026-05-06 (ET)

17:10:00

GoodRx Q1 Revenue $194M Beats Expectations

资讯

GDRX FAQ — answered by Alphio AI

GoodRx Holdings, Inc. is a platform for medication savings in the United States, used by consumers and healthcare professionals. The Company connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The Company's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The Company partners with pharma manufacturers to advertise and integrate their affordable solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications. It operates in the Technology sector (SERVICES-COMPUTER PROCESSING & DATA PREPARATION industry).

GoodRx Holdings Inc (GDRX) appears to be a good buy right now, trading at $3.53, which is below the average analyst target price of $4.50. The stock has shown a positive trend with a 20-day change of +14.98% and a year-to-date change of +28.36%. Although the RSI is at 48.888, indicating a neutral momentum, the forward P/E ratio of 5.4407 suggests that the stock is undervalued compared to its earnings potential. The main risk is the significant decline in Q2 earnings, reporting a net income of $8.54 million, down from $12.84 million last year, which may impact investor confidence.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始